Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population
Open Access
- 27 April 2020
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Hepatology
- Vol. 12 (4), 149-159
- https://doi.org/10.4254/wjh.v12.i4.149
Abstract
BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is a common disorder, with an estimated prevalence ranging from 20% to 35% in the general population. Several scores based on easily measurable biochemical and clinical parameters, including the fatty liver index (FLI), hepatic steatosis index (HSI), lipid accumulation product (LAP), and NAFLD liver fat score (LFS), have been developed for the detection of NAFLD. However, comparative information regarding the efficacy of these scores for predicting NAFLD in population-based samples comprising normal and high-risk individuals is lacking. AIM To evaluate four NAFLD detection scores in two samples with different NAFLD risks. METHODS NAFLD screening was performed in a population-based sample of 50-year-old individuals in Uppsala, Sweden [n = 310; Prospective investigation of obesity, energy and metabolism (POEM) study] and a high-risk population comprising patients with a body mass index > 25 kg/m(2) and either high plasma triglycerides (>= 1.7 mmol/L) or type 2 diabetes (n = 310; EFFECT studies). NAFLD was defined as liver fat > 5.5% using magnetic resonance imaging-proton density fat fraction. FLI, HSI, LAP, and NAFLD LFS were assessed. A logistic regression model was used to evaluate the effectiveness of the different scores. RESULTS The prevalence of NAFLD was 23% in POEM. FLI showed the highest receiver operating characteristic area under the curve (ROC AUC; 0.82) and was significantly better than the LAP score (P = 0.005 vs LAP, P = 0.08 vs LFS, P = 0.12 vs HSI) for detection of NAFLD. The other three indices performed equally in POEM (0.77-0.78). The prevalence of NAFLD was 74% in EFFECT; LFS performed best (ROC AUC 0.80) in this sample. The ROC AUC for LFS (0.80) was significantly higher than that for FLI (P = 0.0019) and LAP (P = 0.0022), but not HSI (P = 0.11). We performed a sensitivity analysis with stratification for the two high-risk subgroups (patients with diabetes or hypertriglyceridemia) from the EFFECT studies. LAP performed best in patients with hypertriglyceridemia. No major differences were observed between the other scores. CONCLUSION The four investigated NAFLD scores performed differently in the populationbased vs high-risk setting. FLI was preferable in the population-based setting, while LFS performed best in the high-risk setting.Keywords
This publication has 20 references indexed in Scilit:
- Relationships between three different tests to evaluate endothelium-dependent vasodilation and cardiovascular risk in a middle-aged sampleJournal Of Hypertension, 2013
- Correlation between liver histology and novel magnetic resonance imaging in adult patients with non‐alcoholic fatty liver disease – MRI accurately quantifies hepatic steatosis in NAFLDAlimentary Pharmacology & Therapeutics, 2012
- A simple index of lipid overaccumulation is a good marker of liver steatosisBMC Gastroenterology, 2010
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver diseaseDigestive and Liver Disease, 2010
- Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic FactorsGastroenterology, 2009
- Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general populationAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical courseBest Practice & Research Clinical Gastroenterology, 2004
- Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicityHepatology, 2004
- Fatty Liver among Persons in a Community in Northern ItalyAnnals of Internal Medicine, 2000
- Prevalence of and Risk Factors for Hepatic Steatosis in Northern ItalyAnnals of Internal Medicine, 2000